Press Releases

  • 19 Oct 2016
    - Press Release

    EFPIA and EBE Welcome NOR-SWITCH Results as a Valuable Step Forward

    EFPIA and EBE welcome the results of the NOR-SWITCH study on biosimilar switching* and acknowledge its preliminary results as a step in the right direction of robust data generation that continues to enhance physician and patient confidence in using biosimilars.

    EFPIA and EBE also welcome the effort of the Norwegian authorities and investigators to initiate and carry out the NOR-SWITCH study.

    Read more |
  • 19 Sep 2016
    - Press Release

    The European biotech ecosystem: EBE position paper recommends how to make funding go further

    Brussels, 19 September 2016

    The European Biopharmaceutical Enterprises (EBE) today published a White Paper that scrutinises funding available for innovative biopharmaceutical entrepreneurs in Europe and explores why fewer successful businesses are built in Europe – despite our exceptional science – than in other world regions.

    Read more | Download Document (547.59 kB)
  • 18 Jun 2016
    - Press Release

    EBE Webinar: "Maintaining Europe's Lead In Regenerative Medicine - New Approaches and Programmes"

    Webinar - 1 July 2016 - 11.45-12.30 CET

    While the EU has had a global lead in ATMP technologies and regulation policy, other countries are moving aggressively into the space.

    The Japanese "Sakigake" accelerated pathway for regenerative medicines, as well as initiatives such as the UK's EAMs and EMA's PRIME are such examples.
    What are the National Governments and European Commission doing specifically to ensure that ATMP technologies are continued to be developed and commercialised in Europe?
    Read more |
  • 17 Jun 2016
    - Press Release

    Compromise Agreement on IVDs is a Solid Step in the Right Direction to enable Personalised Medicine

    Brussels, 17 June 2016: The European Biopharmaceutical Enterprises, EBE, and the European Federation of Pharmaceutical Industries and Associations, EFPIA, welcome the agreement reached between the Council of Ministers and the European Parliament Health Committee (ENVI) on the adoption of the Regulation on In-Vitro Diagnostic (IVD) Medical Devices. This Regulation, adopted alongside the Regulation on Medical Devices, will ensure the increased safety of IVD medical devices and will allow patients to benefit from innovative healthcare solutions in a timely manner.

    Read more | Download Document (132.50 kB)